Cornerstones of CRISPR-Cas in drug discovery and therapy

被引:346
作者
Fellmann, Christof [1 ]
Cowen, Benjamin C. [1 ,2 ]
Lin, Pei-Chun [1 ,2 ,3 ]
Doudna, Jennifer A. [1 ,4 ,5 ,6 ,7 ]
Corn, Jacob E. [1 ,2 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA
[3] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA
[4] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[5] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA
[6] Univ Calif Berkeley, Li Ka Shing Biomed & Hlth Sci Ctr, Berkeley, CA 94720 USA
[7] Lawrence Berkeley Natl Lab, MBIB Div, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
EMBRYONIC STEM-CELLS; HEMATOPOIETIC STEM/PROGENITOR CELLS; GENOME-EDITING SPECIFICITY; ZINC-FINGER NUCLEASES; VIRUS ENTRY REQUIRES; DOUBLE-STRAND BREAKS; HUMAN CANCER-CELLS; OFF-TARGET SITES; IN-VIVO; T-CELLS;
D O I
10.1038/nrd.2016.238
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The recent development of CRISPR-Cas systems as easily accessible and programmable tools for genome editing and regulation is spurring a revolution in biology. Paired with the rapid expansion of reference and personalized genomic sequence information, technologies based on CRISPR-Cas are enabling nearly unlimited genetic manipulation, even in previously difficult contexts, including human cells. Although much attention has focused on the potential of CRISPR-Cas to cure Mendelian diseases, the technology also holds promise to transform the development of therapies to treat complex heritable and somatic disorders. In this Review, we discuss how CRISPR-Cas can affect the next generation of drugs by accelerating the identification and validation of high-value targets, uncovering high-confidence biomarkers and developing differentiated breakthrough therapies. We focus on the promises, pitfalls and hurdles of this revolutionary gene-editing technology, discuss key aspects of different CRISPR-Cas screening platforms and offer our perspectives on the best practices in genome engineering.
引用
收藏
页码:89 / 100
页数:12
相关论文
共 159 条
[1]   Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting [J].
Aguirre, Andrew J. ;
Meyers, Robin M. ;
Weir, Barbara A. ;
Vazquez, Francisca ;
Zhang, Cheng-Zhong ;
Ben-David, Uri ;
Cook, April ;
Ha, Gavin ;
Harrington, William F. ;
Doshi, Mihir B. ;
Kost-Alimova, Maria ;
Gill, Stanley ;
Xu, Han ;
Ali, Levi D. ;
Jiang, Guozhi ;
Pantel, Sasha ;
Lee, Yenarae ;
Goodale, Amy ;
Cherniack, Andrew D. ;
Oh, Coyin ;
Kryukov, Gregory ;
Cowley, Glenn S. ;
Garraway, Levi A. ;
Stegmaier, Kimberly ;
Roberts, Charles W. ;
Golub, Todd R. ;
Meyerson, Matthew ;
Root, David E. ;
Tsherniak, Aviad ;
Hahn, William C. .
CANCER DISCOVERY, 2016, 6 (08) :914-929
[2]  
[Anonymous], 2015, BLOOD
[3]   Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases [J].
Bae, Sangsu ;
Park, Jeongbin ;
Kim, Jin-Soo .
BIOINFORMATICS, 2014, 30 (10) :1473-1475
[4]   The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity [J].
Barretina, Jordi ;
Caponigro, Giordano ;
Stransky, Nicolas ;
Venkatesan, Kavitha ;
Margolin, Adam A. ;
Kim, Sungjoon ;
Wilson, Christopher J. ;
Lehar, Joseph ;
Kryukov, Gregory V. ;
Sonkin, Dmitriy ;
Reddy, Anupama ;
Liu, Manway ;
Murray, Lauren ;
Berger, Michael F. ;
Monahan, John E. ;
Morais, Paula ;
Meltzer, Jodi ;
Korejwa, Adam ;
Jane-Valbuena, Judit ;
Mapa, Felipa A. ;
Thibault, Joseph ;
Bric-Furlong, Eva ;
Raman, Pichai ;
Shipway, Aaron ;
Engels, Ingo H. ;
Cheng, Jill ;
Yu, Guoying K. ;
Yu, Jianjun ;
Aspesi, Peter, Jr. ;
de Silva, Melanie ;
Jagtap, Kalpana ;
Jones, Michael D. ;
Wang, Li ;
Hatton, Charles ;
Palescandolo, Emanuele ;
Gupta, Supriya ;
Mahan, Scott ;
Sougnez, Carrie ;
Onofrio, Robert C. ;
Liefeld, Ted ;
MacConaill, Laura ;
Winckler, Wendy ;
Reich, Michael ;
Li, Nanxin ;
Mesirov, Jill P. ;
Gabriel, Stacey B. ;
Getz, Gad ;
Ardlie, Kristin ;
Chan, Vivien ;
Myer, Vic E. .
NATURE, 2012, 483 (7391) :603-607
[5]   An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level [J].
Bauer, Daniel E. ;
Kamran, Sophia C. ;
Lessard, Samuel ;
Xu, Jian ;
Fujiwara, Yuko ;
Lin, Carrie ;
Shao, Zhen ;
Canver, Matthew C. ;
Smith, Elenoe C. ;
Pinello, Luca ;
Sabo, Peter J. ;
Vierstra, Jeff ;
Voit, Richard A. ;
Yuan, Guo-Cheng ;
Porteus, Matthew H. ;
Stamatoyannopoulos, John A. ;
Lettre, Guillaume ;
Orkin, Stuart H. .
SCIENCE, 2013, 342 (6155) :253-257
[6]   Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells [J].
Beard, C ;
Hochedlinger, K ;
Plath, K ;
Wutz, A ;
Jaenisch, R .
GENESIS, 2006, 44 (01) :23-28
[7]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[8]   Gene essentiality and synthetic lethality in haploid human cells [J].
Blomen, Vincent A. ;
Majek, Peter ;
Jae, Lucas T. ;
Bigenzahn, Johannes W. ;
Nieuwenhuis, Joppe ;
Staring, Jacqueline ;
Sacco, Roberto ;
van Diemen, Ferdy R. ;
Olk, Nadine ;
Stukalov, Alexey ;
Marceau, Caleb ;
Janssen, Hans ;
Carette, Jan E. ;
Bennett, Keiryn L. ;
Colinge, Jacques ;
Superti-Furga, Giulio ;
Brummelkamp, Thijn R. .
SCIENCE, 2015, 350 (6264) :1092-1096
[9]  
Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]
[10]  
Cancer Genome Atlas Research Networks (231 collaborators), 2013, NATURE, V455, P1061